A glycosylated type I membrane protein becomes cytosolic when peptide:: N-glycanase is compromised

被引:105
作者
Blom, D [1 ]
Hirsch, C [1 ]
Stern, P [1 ]
Tortorella, D [1 ]
Ploegh, HL [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
glycoprotein turnover; HCMV; peptide : N-glycanase; siRNA; US2;
D O I
10.1038/sj.emboj.7600090
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human cytomegalovirus-encoded glycoprotein US2 catalyzes proteasomal degradation of Class I major histocompatibility complex (MHC) heavy chains (HCs) through dislocation of the latter from the endoplasmic reticulum ( ER) to the cytosol. During this process, the Class I MHC HCs are deglycosylated by an N-glycanase-type activity. siRNA molecules designed to inhibit the expression of the light chain, beta(2)-microglobulin, block the dislocation of Class I MHC molecules, which implies that US2-dependent dislocation utilizes correctly folded Class I MHC molecules as a substrate. Here we demonstrate it is peptide: N-glycanase ( PNGase or PNG1) that deglycosylates dislocated Class I MHC HCs. Reduction of PNGase activity by siRNA expression in US2-expressing cells inhibits deglycosylation of Class I MHC HC molecules. In PNGase siRNA-treated cells, glycosylated HCs appear in the cytosol, providing the first evidence for the presence of an intact N-linked type I membrane glycoprotein in the cytosol. N-glycanase activity is therefore not required for dislocation of glycosylated Class I MHC molecules from the ER.
引用
收藏
页码:650 / 658
页数:9
相关论文
共 55 条
[1]   The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61β and a cytosolic, deglycosylated intermediary [J].
Bebök, Z ;
Mazzochi, C ;
King, SA ;
Hong, JS ;
Sorscher, EJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) :29873-29878
[2]   Architecture of the protein-conducting channel associated with the translating 80S ribosome [J].
Beckmann, R ;
Spahn, CMT ;
Eswar, N ;
Helmers, J ;
Penczek, PA ;
Sali, A ;
Frank, J ;
Blobel, G .
CELL, 2001, 107 (03) :361-372
[3]   Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors [J].
Bogyo, M ;
McMaster, JS ;
Gaczynska, M ;
Tortorella, D ;
Goldberg, AL ;
Ploegh, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) :6629-6634
[4]   CHARACTERIZATION OF A MONOCLONAL ANTI-BETA-2-MICROGLOBULIN ANTIBODY AND ITS USE IN THE GENETIC AND BIOCHEMICAL-ANALYSIS OF MAJOR HISTOCOMPATIBILITY ANTIGENS [J].
BRODSKY, FM ;
BODMER, WF ;
PARHAM, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1979, 9 (07) :536-545
[5]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[6]   The dolichol pathway of N-linked glycosylation [J].
Burda, P ;
Aebi, M .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1426 (02) :239-257
[7]  
CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125
[8]   Quality control in the endoplasmic reticulum [J].
Ellgaard, L ;
Helenius, A .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (03) :181-191
[9]   ER quality control: towards an understanding at the molecular level [J].
Ellgaard, L ;
Helenius, A .
CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (04) :431-437
[10]   Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein [J].
Fiebiger, E ;
Story, C ;
Ploegh, HL ;
Tortorella, D .
EMBO JOURNAL, 2002, 21 (05) :1041-1053